Literature DB >> 19147357

Restriction of Src activity by Cullin-5.

George S Laszlo1, Jonathan A Cooper.   

Abstract

Src is a nonreceptor tyrosine kinase that coordinates responses to diverse soluble and adhesive signaling molecules and regulates cell proliferation, survival, differentiation and migration. Normally, Src activity is tightly regulated, and Src-catalyzed phosphorylation is counterbalanced by phosphotyrosine phosphatases. However, deregulated mutant Src causes malignant transformation when highly expressed. Src transformation is dose dependent, but it has been unclear how much mutant Src, compared with endogenous Src, is required for transformation. Here, we show that transformation requires high-level overexpression of mutant src mRNA, in part because active Src protein is degraded by ubiquitin-mediated proteolysis. We show that active but not inactive Src protein is downregulated depending on the putative tumor suppressor and E3 ubiquitin ligase component, Cullin-5 (Cul5). Cul5 removal synergizes with physiological levels of mutant src mRNA to increase protein tyrosine phosphorylation, induce morphological transformation, and deregulate growth. Cul5 also represses Src-induced tumorigenesis and regulates Src signaling in normal cells. These results suggest that, when Src is activated by mutation or physiological mechanisms, its effects are limited by Cul5, which downregulates active Src and its phosphorylated substrates. These findings demonstrate the importance of a new mechanism that downregulates Src signaling in cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19147357      PMCID: PMC2730496          DOI: 10.1016/j.cub.2008.12.007

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  40 in total

1.  Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues.

Authors:  N Rosen; J B Bolen; A M Schwartz; P Cohen; V DeSeau; M A Israel
Journal:  J Biol Chem       Date:  1986-10-15       Impact factor: 5.157

2.  A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene.

Authors:  J B Cohen; A D Levinson
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

3.  Predisposition to neoplastic transformation caused by gene replacement of H-ras1.

Authors:  R E Finney; J M Bishop
Journal:  Science       Date:  1993-06-04       Impact factor: 47.728

Review 4.  ras oncogenes in human cancer: a review.

Authors:  J L Bos
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

5.  Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice.

Authors:  A Imamoto; P Soriano
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

6.  Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein.

Authors:  C L Yu; D J Meyer; G S Campbell; A C Larner; C Carter-Su; J Schwartz; R Jove
Journal:  Science       Date:  1995-07-07       Impact factor: 47.728

7.  Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation.

Authors:  D Mukhopadhyay; L Tsiokas; X M Zhou; D Foster; J S Brugge; V P Sukhatme
Journal:  Nature       Date:  1995-06-15       Impact factor: 49.962

8.  Hormonal regulation of the Rous sarcoma virus src gene via a heterologous promoter defines a threshold dose for cellular transformation.

Authors:  E B Jakobovits; J E Majors; H E Varmus
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

9.  Csk suppression of Src involves movement of Csk to sites of Src activity.

Authors:  B W Howell; J A Cooper
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

10.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice.

Authors:  P Soriano; C Montgomery; R Geske; A Bradley
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

View more
  29 in total

1.  A window-of-opportunity clinical trial of dasatinib in women with newly diagnosed endometrial cancer.

Authors:  Linda R Duska; Gina R Petroni; Heather Lothamer; William Faust; Jan H Beumer; Susan M Christner; Anne M Mills; Paula M Fracasso; Sarah J Parsons
Journal:  Cancer Chemother Pharmacol       Date:  2018-12-08       Impact factor: 3.333

2.  Oncogenic tyrosine kinases target Dok-1 for ubiquitin-mediated proteasomal degradation to promote cell transformation.

Authors:  Justyna A Janas; Linda Van Aelst
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

Review 3.  Cell regulation by phosphotyrosine-targeted ubiquitin ligases.

Authors:  Jonathan A Cooper; Tomonori Kaneko; Shawn S C Li
Journal:  Mol Cell Biol       Date:  2015-03-16       Impact factor: 4.272

4.  Cdk5 targets active Src for ubiquitin-dependent degradation by phosphorylating Src(S75).

Authors:  Q Pan; F Qiao; C Gao; B Norman; L Optican; Peggy S Zelenka
Journal:  Cell Mol Life Sci       Date:  2011-03-27       Impact factor: 9.261

5.  Myristoylation and membrane binding regulate c-Src stability and kinase activity.

Authors:  Parag Patwardhan; Marilyn D Resh
Journal:  Mol Cell Biol       Date:  2010-06-28       Impact factor: 4.272

6.  Cullin 5 destabilizes Cas to inhibit Src-dependent cell transformation.

Authors:  Anjali Teckchandani; George S Laszlo; Sergi Simó; Khyati Shah; Carissa Pilling; Alexander A Strait; Jonathan A Cooper
Journal:  J Cell Sci       Date:  2013-11-27       Impact factor: 5.285

7.  Rbx2 regulates neuronal migration through different cullin 5-RING ligase adaptors.

Authors:  Sergi Simó; Jonathan A Cooper
Journal:  Dev Cell       Date:  2013-11-07       Impact factor: 12.270

8.  Reduced cul-5 activity causes aberrant follicular morphogenesis and germ cell loss in Drosophila oogenesis.

Authors:  Jan-Michael Kugler; Christopher Lem; Paul Lasko
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240

Review 9.  Cullin-RING Ligases as attractive anti-cancer targets.

Authors:  Yongchao Zhao; Yi Sun
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Quantitative proteomics identifies a Dab2/integrin module regulating cell migration.

Authors:  Anjali Teckchandani; Natalie Toida; Jake Goodchild; Christine Henderson; Julian Watts; Bernd Wollscheid; Jonathan A Cooper
Journal:  J Cell Biol       Date:  2009-07-06       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.